Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $269 Million - $366 Million
-32,149,622 Reduced 28.01%
82,644,367 $731 Million
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $19.1 Million - $22.7 Million
-2,396,339 Reduced 2.04%
114,793,989 $1.05 Billion
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $165 Million - $287 Million
24,024,045 Added 25.79%
117,190,328 $946 Million
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $288 Million - $406 Million
-38,999,232 Reduced 29.51%
93,166,283 $701 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $1.36 Million - $1.74 Million
-185,235 Reduced 0.14%
132,165,515 $1.24 Billion
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $106 Million - $137 Million
13,474,099 Added 11.33%
132,350,750 $1.06 Billion
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $31.6 Million - $38.4 Million
-3,775,923 Reduced 3.08%
118,876,651 $1.16 Billion
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $59.8 Million - $69.8 Million
-6,040,649 Reduced 4.69%
122,652,574 $1.21 Billion
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $15 Million - $18.5 Million
-1,447,024 Reduced 1.11%
128,693,223 $1.49 Billion
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $282,218 - $361,869
32,778 Added 0.03%
130,140,247 $1.26 Billion
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $175,479 - $259,840
-20,476 Reduced 0.02%
130,107,469 $1.17 Billion
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $301,609 - $487,329
37,144 Added 0.03%
130,127,945 $1.6 Billion
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $5.75 Million - $11.6 Million
-859,876 Reduced 0.66%
130,090,801 $1.17 Billion
Q4 2019

Feb 18, 2020

BUY
$6.53 - $10.72 $138,762 - $227,800
21,250 Added 0.02%
130,950,677 $1.28 Billion
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $229,139 - $357,100
37,198 Added 0.03%
130,929,427 $901 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $21.9 Million - $42.5 Million
2,700,837 Added 2.11%
130,892,229 $1.21 Billion
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $97.2 Million - $125 Million
6,237,109 Added 5.11%
128,191,392 $2.01 Billion
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $45.3 Million - $74 Million
3,105,683 Added 2.61%
121,954,283 $1.88 Billion
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $67.1 Million - $81.7 Million
-3,184,236 Reduced 2.61%
118,848,600 $2.56 Billion
Q2 2018

Aug 14, 2018

BUY
$16.77 - $24.71 $6.1 Million - $8.99 Million
363,631 Added 0.3%
122,032,836 $2.97 Billion
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $382 Million - $506 Million
22,916,493 Added 23.21%
121,669,205 $2.08 Billion
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $322 Million - $547 Million
28,656,135 Added 40.88%
98,752,712 $1.87 Billion
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $1.08 Billion - $2.26 Billion
70,096,577
70,096,577 $1.23 Billion

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.